AGP Executive Report
Last update: 10 hours agoEU Health Tech & Care Access: Sanofi’s Sarclisa (isatuximab) got EU approval in a subcutaneous form delivered via an on-body injector, aiming to cut clinic visits for multiple myeloma patients. Nutrition & Brain Health: A UK trial in the British Journal of Nutrition found that counting one daily serving of 100% fruit juice toward “5-a-day” increased fruit intake and was linked to lower depression scores, with no short-term worsening in key blood markers. Dementia Risk & Diet: New Danish research links nitrate source to dementia risk: higher nitrate from vegetables tracked with lower risk, while nitrate/nitrite from animal foods, processed meats, and drinking water tracked with higher risk. Respiratory Treatment in Spain: Lupin and Spain’s ERN plan to launch Luforbec (beclometasone/formoterol) for adult asthma and COPD using a pressurised metered-dose inhaler. Cognitive Health Industry Push: Aker BioMarine kicked off Vitality Month 2026 in Frankfurt with “Braingevity,” spotlighting precision nutrition and the gut–brain axis for healthy ageing. Mental Health Online Safety: A Cyprus-focused legal analysis raises the question of whether doomscrolling could create liability via personality rights and mental harm.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
